Home › Allied-Bristol Life Sciences Licenses Platform Technology And Lead Molecules From Yale University
 

Keywords :   


Allied-Bristol Life Sciences Licenses Platform Technology And Lead Molecules From Yale University

2015-09-02 07:19:10| drugdiscoveryonline News Articles

Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise jointly owned between Allied Minds and Bristol-Myers Squibb Company, announced that it has entered into a worldwide licensing agreement with Yale University for a proprietary platform technology and associated lead molecules that will be further developed to treat diseases such as prostate cancer, a leading cause of cancer-related deaths among American men

Tags: life technology university lead

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11Health stocks hit after Trump taps RFK for top job
15.11Tropical Storm Sara Graphics
15.11Tropical Storm Sara Forecast Discussion Number 8
15.11Tropical Storm Sara Wind Speed Probabilities Number 8
15.11Tropical Storm Sara Public Advisory Number 8
15.11JBS reports strong Q3 financial results
15.11 20213 105S P7905-P
15.11 ()
More »